Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Sam Blackman, co-founder and former Chief Medical Officer of Day One Biopharmaceuticals, board member of the Pediatric Brain Tumor Foundation, Bonum Therapeutics and CureSearch for Children's Cancer, and the new Entrepreneur in Residence at Google Ventures. Sam talks about his career journey from physician to biotech executive, and navigating the complexities of clinical trials, especially within pediatric oncology. He also discusses the critical need to connect the science, patients, and investment thesis together into a coherent story when fundraising in drug development.
- 2:37 - How he was pulled to pediatric medicine
- 6:00 - His decision to transition into drug development to impact exponentially more patients.
- 16:40 - The importance of connecting you vision to your company name
- 26:04 - How making those risky decisions in drug development can have profound impacts on patient outcomes
- 40:00 - The Power of Storytelling in Science and Business
- 47:57 - Advice for biotech entrepreneurs seeking capital
Related Insights
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Related Insights
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021